Literature DB >> 26168680

[Antibiotic Resistance and Serotype Pattern of Streptococcus pneumoniae Isolated from Children in St. Petersburg in 2010-2013].

O S Kalinogorskaya, S S Belanov, M O Volkova, V V Gostev, S V Sidorenko.   

Abstract

The surveillance of the serotype pattern and antibiotic resistance of S. pneumoniae in various geographical regions is required for the validity of rational etiotrophic therapy of pneumococcal infections and the choice of the optimal vaccines for their prophylaxis. 250 S. pneumoniae isolates from children with acute otitis or pneumonia and healthy carriers in St. Petersburg in 2010-2013 were investigated. The analysis of the serotype pattern of the pneumococci showed that 13-valent conjugate vaccine was the most active (86.1% of pneumococci causing pneumonia and 86.4% of pneumococci causing acute otitis). The isolates were higly resistant to beta-lactams and macrolides. By the EUCAST criteria, the decrease in the susceptibility to penicillin, cefotaxime, erythromycin and ceftarolin was observed in 32.4%, 14%, 33.2 and 6% of the isolates respectively. 22.4% of the isolates showed associate resistance to penicillin and erythromycin.. No resistance to moxifloxacin was detected. The frequency of resistance to tetracycline, co-trimoxasole and chloramphenicol in various patients ranged within 30-50%. The prevalence of the antibiotic resistance was mainly characteristic of the isolates serotypes 19A, 19F, 14 and serogroup 6.

Entities:  

Mesh:

Year:  2015        PMID: 26168680

Source DB:  PubMed          Journal:  Antibiot Khimioter        ISSN: 0235-2990


  2 in total

1.  Principles of antibiotic application in children with lobar pneumonia: Step-up or step-down.

Authors:  Yan Li; Feng Han; Yan Yang; Jianwei Chu
Journal:  Exp Ther Med       Date:  2017-04-10       Impact factor: 2.447

2.  A Qualitative Analysis of the Culture of Antibiotic Use for Upper Respiratory Tract Infections Among Patients in Northwest Russia.

Authors:  Lourdes Cantarero-Arevalo; Lotte S Nørgaard; Sofia K Sporrong; Ramune Jacobsen; Anna Birna Almarsdóttir; Johanne M Hansen; Dmitry Titkov; Svetlana Rachina; Ekaterina Panfilova; Viktoria Merkulova; Olga Eseva; Nadezhda Riabkova; Susanne Kaae
Journal:  Front Pharmacol       Date:  2022-01-31       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.